A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer

Emily M. Fox, Todd W. Miller, Justin M. Balko, Maria G. Kuba, Violeta Sánchez, R. Adam Smith, Shuying Liu, Ana María González-Angulo, Gordon Mills, Fei Ye, Yu Shyr, H. Charles Manning, Elizabeth Buck, Carlos L. Arteaga

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

Estrogen receptor α (ER)-positive breast cancers adapt to hormone deprivation and become resistant to antiestrogens. In this study, we sought to identify kinases essential for growth of ER + breast cancer cells resistant to long-term estrogen deprivation (LTED). A kinome-wide siRNA screen showed that the insulin receptor (InsR) is required for growth of MCF-7/LTED cells. Knockdown of InsR and/or insulin-like growth factor-I receptor (IGFIR) inhibited growth of 3 of 4 LTED cell lines. Inhibition of InsR and IGF-IR with the dual tyrosine kinase inhibitor OSI-906 prevented the emergence of hormone-independent cells and tumors in vivo, inhibited parental and LTED cell growth and PI3K/AKT signaling, and suppressed growth of established MCF-7 xenografts in ovariectomized mice, whereas treatment with the neutralizing IGF-IR monoclonal antibody MAB391 was ineffective. Combined treatment with OSI-906 and the ER downregulator fulvestrant more effectively suppressed hormone-independent tumor growth than either drug alone. Finally, an insulin/IGF-I gene expression signature predicted recurrencefree survival in patients with ER + breast cancer treated with the antiestrogen tamoxifen. We conclude that therapeutic targeting of both InsR and IGF-IR should be more effective than targeting IGF-IR alone in abrogating resistance to endocrine therapy in breast cancer.

Original languageEnglish (US)
Pages (from-to)6773-6784
Number of pages12
JournalCancer Research
Volume71
Issue number21
DOIs
StatePublished - Nov 1 2011
Externally publishedYes

Fingerprint

IGF Type 1 Receptor
Insulin Receptor
Hormones
Insulin
Breast Neoplasms
Estrogen Receptors
Estrogens
Growth
Estrogen Receptor Modulators
Tamoxifen
Therapeutics
Phosphatidylinositol 3-Kinases
Insulin-Like Growth Factor I
Transcriptome
Heterografts
Protein-Tyrosine Kinases
Small Interfering RNA
Neoplasms
Phosphotransferases
Monoclonal Antibodies

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Fox, E. M., Miller, T. W., Balko, J. M., Kuba, M. G., Sánchez, V., Smith, R. A., ... Arteaga, C. L. (2011). A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. Cancer Research, 71(21), 6773-6784. https://doi.org/10.1158/0008-5472.CAN-11-1295

A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. / Fox, Emily M.; Miller, Todd W.; Balko, Justin M.; Kuba, Maria G.; Sánchez, Violeta; Smith, R. Adam; Liu, Shuying; González-Angulo, Ana María; Mills, Gordon; Ye, Fei; Shyr, Yu; Manning, H. Charles; Buck, Elizabeth; Arteaga, Carlos L.

In: Cancer Research, Vol. 71, No. 21, 01.11.2011, p. 6773-6784.

Research output: Contribution to journalArticle

Fox, EM, Miller, TW, Balko, JM, Kuba, MG, Sánchez, V, Smith, RA, Liu, S, González-Angulo, AM, Mills, G, Ye, F, Shyr, Y, Manning, HC, Buck, E & Arteaga, CL 2011, 'A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer', Cancer Research, vol. 71, no. 21, pp. 6773-6784. https://doi.org/10.1158/0008-5472.CAN-11-1295
Fox, Emily M. ; Miller, Todd W. ; Balko, Justin M. ; Kuba, Maria G. ; Sánchez, Violeta ; Smith, R. Adam ; Liu, Shuying ; González-Angulo, Ana María ; Mills, Gordon ; Ye, Fei ; Shyr, Yu ; Manning, H. Charles ; Buck, Elizabeth ; Arteaga, Carlos L. / A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. In: Cancer Research. 2011 ; Vol. 71, No. 21. pp. 6773-6784.
@article{3a35397acfe041ad8211fb9a075c72ea,
title = "A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer",
abstract = "Estrogen receptor α (ER)-positive breast cancers adapt to hormone deprivation and become resistant to antiestrogens. In this study, we sought to identify kinases essential for growth of ER + breast cancer cells resistant to long-term estrogen deprivation (LTED). A kinome-wide siRNA screen showed that the insulin receptor (InsR) is required for growth of MCF-7/LTED cells. Knockdown of InsR and/or insulin-like growth factor-I receptor (IGFIR) inhibited growth of 3 of 4 LTED cell lines. Inhibition of InsR and IGF-IR with the dual tyrosine kinase inhibitor OSI-906 prevented the emergence of hormone-independent cells and tumors in vivo, inhibited parental and LTED cell growth and PI3K/AKT signaling, and suppressed growth of established MCF-7 xenografts in ovariectomized mice, whereas treatment with the neutralizing IGF-IR monoclonal antibody MAB391 was ineffective. Combined treatment with OSI-906 and the ER downregulator fulvestrant more effectively suppressed hormone-independent tumor growth than either drug alone. Finally, an insulin/IGF-I gene expression signature predicted recurrencefree survival in patients with ER + breast cancer treated with the antiestrogen tamoxifen. We conclude that therapeutic targeting of both InsR and IGF-IR should be more effective than targeting IGF-IR alone in abrogating resistance to endocrine therapy in breast cancer.",
author = "Fox, {Emily M.} and Miller, {Todd W.} and Balko, {Justin M.} and Kuba, {Maria G.} and Violeta S{\'a}nchez and Smith, {R. Adam} and Shuying Liu and Gonz{\'a}lez-Angulo, {Ana Mar{\'i}a} and Gordon Mills and Fei Ye and Yu Shyr and Manning, {H. Charles} and Elizabeth Buck and Arteaga, {Carlos L.}",
year = "2011",
month = "11",
day = "1",
doi = "10.1158/0008-5472.CAN-11-1295",
language = "English (US)",
volume = "71",
pages = "6773--6784",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "21",

}

TY - JOUR

T1 - A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer

AU - Fox, Emily M.

AU - Miller, Todd W.

AU - Balko, Justin M.

AU - Kuba, Maria G.

AU - Sánchez, Violeta

AU - Smith, R. Adam

AU - Liu, Shuying

AU - González-Angulo, Ana María

AU - Mills, Gordon

AU - Ye, Fei

AU - Shyr, Yu

AU - Manning, H. Charles

AU - Buck, Elizabeth

AU - Arteaga, Carlos L.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Estrogen receptor α (ER)-positive breast cancers adapt to hormone deprivation and become resistant to antiestrogens. In this study, we sought to identify kinases essential for growth of ER + breast cancer cells resistant to long-term estrogen deprivation (LTED). A kinome-wide siRNA screen showed that the insulin receptor (InsR) is required for growth of MCF-7/LTED cells. Knockdown of InsR and/or insulin-like growth factor-I receptor (IGFIR) inhibited growth of 3 of 4 LTED cell lines. Inhibition of InsR and IGF-IR with the dual tyrosine kinase inhibitor OSI-906 prevented the emergence of hormone-independent cells and tumors in vivo, inhibited parental and LTED cell growth and PI3K/AKT signaling, and suppressed growth of established MCF-7 xenografts in ovariectomized mice, whereas treatment with the neutralizing IGF-IR monoclonal antibody MAB391 was ineffective. Combined treatment with OSI-906 and the ER downregulator fulvestrant more effectively suppressed hormone-independent tumor growth than either drug alone. Finally, an insulin/IGF-I gene expression signature predicted recurrencefree survival in patients with ER + breast cancer treated with the antiestrogen tamoxifen. We conclude that therapeutic targeting of both InsR and IGF-IR should be more effective than targeting IGF-IR alone in abrogating resistance to endocrine therapy in breast cancer.

AB - Estrogen receptor α (ER)-positive breast cancers adapt to hormone deprivation and become resistant to antiestrogens. In this study, we sought to identify kinases essential for growth of ER + breast cancer cells resistant to long-term estrogen deprivation (LTED). A kinome-wide siRNA screen showed that the insulin receptor (InsR) is required for growth of MCF-7/LTED cells. Knockdown of InsR and/or insulin-like growth factor-I receptor (IGFIR) inhibited growth of 3 of 4 LTED cell lines. Inhibition of InsR and IGF-IR with the dual tyrosine kinase inhibitor OSI-906 prevented the emergence of hormone-independent cells and tumors in vivo, inhibited parental and LTED cell growth and PI3K/AKT signaling, and suppressed growth of established MCF-7 xenografts in ovariectomized mice, whereas treatment with the neutralizing IGF-IR monoclonal antibody MAB391 was ineffective. Combined treatment with OSI-906 and the ER downregulator fulvestrant more effectively suppressed hormone-independent tumor growth than either drug alone. Finally, an insulin/IGF-I gene expression signature predicted recurrencefree survival in patients with ER + breast cancer treated with the antiestrogen tamoxifen. We conclude that therapeutic targeting of both InsR and IGF-IR should be more effective than targeting IGF-IR alone in abrogating resistance to endocrine therapy in breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=80155131176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80155131176&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-11-1295

DO - 10.1158/0008-5472.CAN-11-1295

M3 - Article

C2 - 21908557

AN - SCOPUS:80155131176

VL - 71

SP - 6773

EP - 6784

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 21

ER -